fda warning letters compounded semaglutide september 2025 Why the Issued 30 to Telehealth Sites Marketing GLP-1s Have patients been harmed by

Understanding baseline predisposition markers can help providers optimize initial dosing strategy, potentially reducing side effects and improving adherence

Plan limitations may often include quantity limits (usually one pen per month) and restrictions on using multiple GLP-1s together

The brand publishes structured pricing tiers, a 28-day refund window with two specific qualifying circumstances, a Telehealth Informed Consent process, a HIPAA Notice of Privacy Practices, exclusionary clinical criteria managed by CareValidate Health, and explicit language stating that compounded GLP-1 medications are not FDA-approved

All these changes can lead to unexpected pregnancy, which for some patients is a welcome surprise

When to Speak to Your GP About Topiramate Whether you are currently taking topiramate for a licensed indication or have encountered it in the context of weight loss, there are several important reasons to speak with your GP or specialist

Semaglutide is a GLP-1 receptor agonist, and it works by stimulating insulin release and inhibiting glucagon secretion, which helps lower blood sugar levels